Home » Topics » Regulatory

Regulatory
RSS

FDA approves Xeloda/Taxotere combination therapy for metastatic breast cancer

Sep. 13, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Janssen seeks FDA approval of new long-acting Risperdal formulation

Sep. 10, 2001

Ortec's OrCel approved for healing donor site wounds in burn victims

Sep. 10, 2001

Pariet receives E.U. clearance for treatment of symptomatic GERD

Sep. 7, 2001

FDA approves Topamax for treatment of Lennox-Gastaut syndrome

Sep. 6, 2001

Feridex I.V. sNDA deemed not approvable by FDA

Sep. 4, 2001

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

Study investigates Toprol-XL for reversal of cardiac remodeling

Sep. 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...